Sweta Gupta

Researchers conducted a meta-analysis to assess the effects of statin use on mortality outcomes in patients with SARS-CoV-2 infection.

Researchers conducted a study to determine whether SARS-CoV-2 viral RNA detected in the bloodstreams of patients with COVID-19 is reflective of viremia or related to host immune responses and outcomes.

In a randomized clinical trial, researchers assessed the effectiveness of umifenovir in combination with other drugs for the treatment of patients hospitalized with moderate to severe COVID-19.

In this meta-analysis of studies on COVID-19 and SARS, researchers compared the association between all-cause mortality and treatment with glucocorticoids.

Researchers conducted a multi-center, open-label, randomized controlled trial to compare the effects of enoxaparin at the standard prophylactic dose with the intermediate dose for the treatment of adult patients with severe COVID-19.

The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.

Researchers studied patients with pulmonary tuberculosis to better understand the impact of sex on mortality and sputum microbiological status after treatment initiation.

Researchers compared trends in antibiotic prescription rates during the period preceding the pneumococcal conjugate vaccine (PCV), as well as the early and late PCV periods, among Jewish vs Bedouin children.

Researchers conducted a phase 3 trial to ascertain whether treatment regimens including rifapentine with or without moxifloxacin can provide a lasting cure for drug-susceptible pulmonary tuberculosis in 4 months vs 6 months of standard therapy.

Researchers compared the antibody responses of 2 age groups, one younger than 60 years and one older than 80 years, to the first and second doses of the Pfizer-BioNTech COVID-19 vaccination.

A team of investigators sought to estimate the burden of acute respiratory illness in ambulatory care settings for 12 respiratory viruses in Washington state during the 2018-2019 influenza season.

Investigators conducted a systematic review and meta-analysis of 37 studies that used a test-negative design to evaluate IVE against influenza-associated hospitalization in children.

Study authors evaluated the safety and efficacy of intravenous immunoglobulin plus the standard of care in the treatment of COVID-19 patients with moderate pneumonia.

Study authors evaluated the safety and efficacy of intravenous immunoglobulin plus the standard of care in the treatment of COVID-19 patients with moderate pneumonia.

An interim phase 3 trial shows promising results for the Russian heterologous recombinant adenovirus-based SARS-CoV-2 vaccine.

Study authors conducted a retrospective study to determine the anti-SARS-CoV-2 IgG antibody levels in convalescent plasma used to treat hospitalized patients with COVID-19.

Study authors investigated the association between HIV diagnosis and COVID-19 diagnosis, hospitalization, and death in New York State.

The acceleration of the COVID-19 pandemic continues to stress health care systems and exacerbate disparities in many communities, highlighting the importance of identifying patients at elevated risk of severe disease for COVID-19 vaccine prioritization.

Investigators quantified the risk of antenatal influenza and examined its association with perinatal outcomes.

Researchers assessed whether pre-existing antibodies to influenza, which are shaped by early infection and subsequent exposures, impact children’s responses to influenza vaccination.

Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.

Study authors explored the challenges in assessing the efficacy of COVID-19 vaccines and discussed the caveats needed to interpret efficacy endpoints.

Researchers assessed if use of intravenous remdesivir in hospitalized patients with coronavirus disease 2019 infection affected time to recovery and clinical status on days 15 and 29.

Investigators compared the prevalence of HIV among patients hospitalized with COVID-19 compared to the general population and sought to determine whether patients with HIV had higher susceptibility to COVID-19.

Investigators assessed the incidence of obstructive sleep apnea in patients with HIV and the comorbidities associated with increased incidence.

Study authors assessed whether azithromycin in addition to a hydroxychloroquine regimen shows positive results in clinical improvement or mortality reduction in patients hospitalized with severe COVID-19.

A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.

Investigators conducted a single-center study to evaluate the anti-SARS-CoV-2 antibodies at baseline and 60 days in health care personnel, who are at particular risk if antibodies level decline.

Findings from a study published in JAMA Network Open suggest that rigorous infection control measures may be associated with minimized risk and provide reassurance to patients concerned about contracting COVID-19 in hospitals.

Researchers compared 3 immunochromatographic assays (Sienna™, Wondfo®, and Prometheus™) to detect antibodies against SARS-CoV-2 in serum samples, using RT-qPCR as a reference.